p63 controls cell migration and invasion by transcriptional regulation of MTSS1 (original) (raw)

• Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305–316.
  Article CAS Google Scholar
• Yang A, McKeon F . P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 2000; 1: 199–207.
  Article CAS Google Scholar
• Levine AJ, Tomasini R, McKeon FD, Mak TW, Melino G . The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol 2011; 12: 259–265.
  Article CAS Google Scholar
• Giacobbe A, Bongiorno-Borbone L, Bernassola F, Terrinoni A, Markert EK, Levine AJ et al. p63 regulates glutaminase 2 expression. Cell Cycle 2013; 12: 1395–1405.
  Article CAS Google Scholar
• Flores ER . The roles of p63 in cancer. Cell Cycle 2007; 6: 300–304.
  Article CAS Google Scholar
• Candi E, Dinsdale D, Rufini A, Salomoni P, Knight RA, Mueller M et al. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 2007; 6: 274–285.
  Article CAS Google Scholar
• Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H et al. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 2005; 24: 2458–2471.
  Article CAS Google Scholar
• Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW . p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006; 9: 45–56.
  Article CAS Google Scholar
• Trink B, Osada M, Ratovitski E, Sidransky D . p63 transcriptional regulation of epithelial integrity and cancer. Cell Cycle 2007; 6: 240–245.
  Article CAS Google Scholar
• Candi E, Agostini M, Melino G, Bernassola F . How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. Hum Mut 2014; 35: 702–714.
  Article CAS Google Scholar
• Graziano V, De Laurenzi V . Role of p63 in cancer development. Biochim Biophys Acta 2011; 1816: 57–66.
  CAS PubMed Google Scholar
• Melino G . p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 2011; 18: 1487–1499.
  Article CAS Google Scholar
• Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986–990.
  Article CAS Google Scholar
• Ramsey MR, Wilson C, Ory B, Rothenberg SM, Faquin W, Mills AA et al. FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J Clin Invest 2013; 123: 3525–3538.
  Article CAS Google Scholar
• Missero C, Antonini D . Crosstalk among p53 family members in cutaneous carcinoma. Exp Dermatol 2014; 23: 143–146.
  Article CAS Google Scholar
• Wang X, Mori I, Tang W, Nakamura M, Nakamura Y, Sato M et al. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer 2002; 9: 216–219.
  Article Google Scholar
• Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001; 25: 1054–1060.
  Article CAS Google Scholar
• Memmi EM, Sanarico AG, Giacobbe A, Peschiaroli A, Frezza V, Cicalese A et al. p63 sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling. Proc Nat Acad Sci USA 2015; 112: 3499–3504.
  Article CAS Google Scholar
• Du Z, Li J, Wang L, Bian C, Wang Q, Liao L et al. Overexpression of DeltaNp63alpha induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway. Cancer Sci 2010; 101: 2417–2424.
  Article CAS Google Scholar
• Chakrabarti R, Wei Y, Hwang J, Hang X, Andres Blanco M, Choudhury A et al. DeltaNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling. Nat Cell Biol 2014; 16: 1004–1015.
  Article CAS Google Scholar
• Cheung KJ, Gabrielson E, Werb Z, Ewald AJ . Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 2013; 155: 1639–1651.
  Article CAS Google Scholar
• Machesky LM, Johnston SA . MIM: a multifunctional scaffold protein. J Mol Med 2007; 85: 569–576.
  Article CAS Google Scholar
• Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA . p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006; 20: 3185–3197.
  Article CAS Google Scholar
• Xie F, Ye L, Ta M, Zhang L, Jiang WG . MTSS1: a multifunctional protein and its role in cancer invasion and metastasis. Front Biosci 2011; 3: 621–631.
  Article Google Scholar
• Parr C, Jiang WG . Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer 2009; 45: 1673–1683.
  Article CAS Google Scholar
• Lee YG, Macoska JA, Korenchuk S, Pienta KJ . MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 2002; 4: 291–294.
  Article CAS Google Scholar
• Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu X et al. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene 2012; 31: 2298–2308.
  Article CAS Google Scholar
• Kedmi M, Ben-Chetrit N, Korner C, Mancini M, Ben-Moshe NB, Lauriola M et al. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. Sci Signal 2015; 8: ra29.
  Article Google Scholar
• Dawson JC, Timpson P, Kalna G, Machesky LM . Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells. Oncogene 2012; 31: 1781–1793.
  Article CAS Google Scholar
• Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang Y et al. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med 2011; 9: 95.
  Article Google Scholar
• Mertz KD, Pathria G, Wagner C, Saarikangas J, Sboner A, Romanov J et al. MTSS1 is a metastasis driver in a subset of human melanomas. Nat Commun 2014; 5: 3465.
  Article Google Scholar
• Mattila PK, Pykalainen A, Saarikangas J, Paavilainen VO, Vihinen H, Jokitalo E et al. Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich membranes by an inverse BAR domain-like mechanism. J Cell Biol 2007; 176: 953–964.
  Article CAS Google Scholar
• Bompard G, Sharp SJ, Freiss G, Machesky LM . Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B. J Cell Sci 2005; 118: 5393–5403.
  Article CAS Google Scholar
• Wang W, Eddy R, Condeelis J . The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007; 7: 429–440.
  Article CAS Google Scholar
• Bergholz J, Zhang Y, Wu J, Meng L, Walsh EM, Rai A et al. DeltaNp63alpha regulates Erk signaling via MKP3 to inhibit cancer metastasis. Oncogene 2014; 33: 212–224.
  Article CAS Google Scholar
• Fukushima H, Koga F, Kawakami S, Fujii Y, Yoshida S, Ratovitski E et al. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Res 2009; 69: 9263–9270.
  Article CAS Google Scholar
• Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH et al. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 2012; 109: 15312–15317.
  Article CAS Google Scholar
• Cho MS, Chan IL, Flores ER . DeltaNp63 transcriptionally regulates brachyury, a gene with diverse roles in limb development, tumorigenesis and metastasis. Cell Cycle 2010; 9: 2434–2441.
  Article CAS Google Scholar
• Lee KB, Ye S, Park MH, Park BH, Lee JS, Kim SM . p63-Mediated activation of the beta-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis. Cancer Lett 2014; 353: 124–132.
  Article CAS Google Scholar
• Yang X, Lu H, Yan B, Romano RA, Bian Y, Friedman J et al. DeltaNp63 versatilely regulates a Broad NF-kappaB gene program and promotes squamous epithelial proliferation, migration, and inflammation. Cancer Res 2011; 71: 3688–3700.
  Article CAS Google Scholar
• Matin RN, Chikh A, Chong SL, Mesher D, Graf M, Sanza P et al. p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis. J Exp Med 2013; 210: 581–603.
  Article CAS Google Scholar
• Malatesta M, Peschiaroli A, Memmi EM, Zhang J, Antonov A, Green DR et al. The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity. Oncogene 2013; 32: 4721–4726.
  Article CAS Google Scholar
• Velletri T, Romeo F, Tucci P, Peschiaroli A, Annicchiarico-Petruzzelli M, Niklison-Chirou MV et al. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle 2013; 12: 3564–3573.
  Article CAS Google Scholar
• Peschiaroli A, Scialpi F, Bernassola F, El Sherbini el S, Melino G . The E3 ubiquitin ligase WWP1 regulates DeltaNp63-dependent transcription through Lys63 linkages. Biochem Biophys Res Commun 2010; 402: 425–430.
  Article CAS Google Scholar
• Amelio I, Gostev M, Knight RA, Willis AE, Melino G, Antonov AV . DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information. Cell Death Dis 2014; 5: e1051.
  Article CAS Google Scholar
• Antonov AV, Krestyaninova M, Knight RA, Rodchenkov I, Melino G, Barlev NA . PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome. Oncogene 2014; 33: 1621–1628.
  Article CAS Google Scholar
• Celardo I, Grespi F, Antonov A, Bernassola F, Garabadgiu AV, Melino G et al. Caspase-1 is a novel target of p63 in tumor suppression. Cell Death Dis 2013; 4: e645.
  Article CAS Google Scholar